Pharmacy and medicine storage: what the rules actually require
EU Good Distribution Practice guidelines set four requirements that shape every monitoring installation: map the temperature before use, place sensors where extremes occur, calibrate against a national or international measurement standard, and keep the records for at least five years.
EnviSensor Team
In short
- EU GDP guidelines require an initial temperature mapping exercise of the storage area before use, carried out under representative conditions.
- Sensors belong where the extremes are, not where they are convenient; mapping is repeated after significant modifications or when risk assessment indicates.
- Calibration must be traceable to a national or international measurement standard, at intervals based on risk and reliability assessment.
- Records are kept for the period stated in national legislation but at least five years; transport monitoring equipment is calibrated at least once a year.
- WHO defines normal storage as 15–25 °C in dry, well-ventilated premises, and refrigerated storage as 2–8 °C without freezing.
What EU Good Distribution Practice requires
The reference document across the European Union is the Commission guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use. Four of its provisions determine how a monitoring system must be designed.
Temperature mapping
Section 3.2.1 requires that an initial temperature mapping exercise should be carried out on the storage area before use, under representative conditions. Monitoring equipment is then located according to the results of that exercise, ensuring sensors are positioned in areas that experience the extremes of fluctuation. Mapping is repeated according to risk assessment or whenever significant modifications are made to the facility or equipment.
This is the provision most often overlooked. A single sensor placed at eye level next to the door describes the door, not the storage area.
Calibration and traceability
Section 3.3 requires equipment to be calibrated at intervals determined on the basis of a risk and reliability assessment, and states the key principle plainly: calibration of equipment should be traceable to a national or international measurement standard.
Alarms and records
Appropriate alarm systems must be in place to warn of excursions from predefined storage conditions, with alarm levels set appropriately and alarms tested regularly. Documentation is retained for the period stated in national legislation, but at least five years. For transport, monitoring equipment in vehicles and containers is maintained and calibrated at least once a year, and vehicles with regulated temperature are mapped under representative conditions taking seasonal variation into account.
Storage temperature ranges
Conditions for a specific product follow from its Summary of Product Characteristics and package labelling. General definitions come from the WHO guide to good storage practices for pharmaceuticals:
| Labelling | Meaning |
|---|---|
| Normal storage conditions | dry, well-ventilated premises at 15–25 °C, or up to 30 °C depending on climatic conditions |
| Store between 2 and 8 °C | under refrigeration, no freezing |
| Store below 8 °C | below 8 °C |
| Store between −5 and −20 °C | in a freezer |
| Store below −18 °C | in a deep freezer |
The phrase no freezing in the refrigerated range carries more weight than it appears to. It is not a footnote — it is a separate failure mode, and one that conventional indicators do not catch.
The failure nobody sees: freezing
A systematic literature review published in Vaccine examined studies of the vaccine cold chain and found that between 14% and 35% of refrigerators or transport shipments had exposed vaccine to freezing temperatures. In studies that examined all segments of distribution, between 75% and 100% of shipments were exposed. The authors also observed that more rigorous study designs were associated with higher levels of detected freeze exposure — meaning the better you look, the more you find.
This matters because freezing damages adsorbed vaccines irreversibly, and because the most widespread monitoring aid does not detect it. WHO notes that vaccine vial monitors record cumulative heat exposure but do not record exposure to freezing. An electronic logger that captures minimum values between readings is the only practical way to see it.
Calibration certificate versus a manufacturer document
GDP requires traceability to a measurement standard. In metrological terms, metrological traceability is the property of a measurement result whereby the result can be related to a reference through a documented unbroken chain of calibrations, each contributing to the measurement uncertainty.
In practice this means two things are acceptable as evidence: a calibration certificate issued by an accredited calibration laboratory bearing the accreditation symbol of a body that is a signatory to the ILAC Mutual Recognition Arrangement, or calibration performed by a national metrology institute. Accreditation of calibration laboratories is granted against ISO/IEC 17025.
A document supplied by a device manufacturer that carries no accreditation symbol does not demonstrate traceability, whatever it is titled. When buying a logger for regulated storage, it is worth checking the certificate for the accreditation symbol and the stated measurement uncertainty — and confirming the laboratory appears in its national accreditation body register.
What this means for a pharmacy or a warehouse
- Map before you install. Run a mapping exercise under representative conditions and place sensors where the extremes actually occur.
- Check the certificate, not the marketing. Look for the accreditation symbol and the measurement uncertainty.
- Record minimum and maximum between readings. An excursion that happens overnight is invisible to a system that reports only instantaneous values.
- Test the alarm path. GDP requires alarms to be tested regularly; a notification channel nobody has verified is not a control.
- Keep the data exportable. Records must survive at least five years and be producible on request.
National implementations add their own detail on top of the EU baseline — some countries specify equipment requirements for refrigerators, documentation content or the handling of excursions — so the applicable national rules should always be checked alongside the GDP guidelines.
Frequently asked questions
What does EU Good Distribution Practice require for temperature monitoring?
An initial temperature mapping exercise of the storage area before use under representative conditions, monitoring equipment positioned where extremes of fluctuation occur, calibration traceable to a national or international measurement standard at risk-based intervals, alarm systems that are tested regularly, and record retention of at least five years.
What temperature should medicines be stored at?
WHO defines normal storage conditions as dry, well-ventilated premises at 15–25 °C, or up to 30 °C depending on climatic conditions. Refrigerated storage means 2–8 °C without freezing, and freezer storage between −5 and −20 °C. Conditions for a specific product follow from its Summary of Product Characteristics.
Is a manufacturer certificate enough, or is an accredited calibration certificate needed?
GDP requires calibration traceable to a national or international measurement standard. Evidence of traceability is a certificate from an accredited calibration laboratory bearing the accreditation symbol of an ILAC MRA signatory, or calibration by a national metrology institute. A manufacturer document without an accreditation symbol does not demonstrate traceability.
How often must monitoring equipment be calibrated?
GDP requires calibration at intervals determined on the basis of a risk and reliability assessment rather than a fixed universal period. For temperature monitoring equipment in vehicles and containers used for transport, the guidelines require maintenance and calibration at least once a year.
Why is freezing a bigger risk than heat for some medicines?
Freezing irreversibly damages adsorbed vaccines, and it often goes undetected. A systematic review found that between 14% and 35% of refrigerators or shipments had exposed vaccine to freezing temperatures. WHO notes that vaccine vial monitors record cumulative heat exposure but do not record freezing, so an electronic logger recording minimum values is needed to catch it.
Sources
- European Commission Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01)
- WHO, Guide to good storage practices for pharmaceuticals, Technical Report Series 902, Annex 9
- Matthias i in., Freezing temperatures in the vaccine cold chain: a systematic literature review, Vaccine 2007;25(20):3980–6
- WHO, How to monitor temperatures in the vaccine supply chain (WHO/IVB/15.04)
- ISO/IEC 17025 — General requirements for the competence of testing and calibration laboratories
- ILAC P10 — polityka spójności pomiarowej wyników pomiarów
Need monitoring at your site?
We will help you choose sensors and the way they run — locally on your LAN, in your own monitoring system or in the CE MonitorApp cloud.